Wilding GE - Search Results

1

Extent of disease burden determined with magnetic resonance imaging of the bone marrow is predictive of survival outcome in patients with multiple myeloma.

Ailawadhi S, Abdelhalim AN, Derby L, Mashtare TL, Miller KC, Wilding GE, Alberico RA, Gottlieb R, Klippenstein DL, Lee K, Chanan-Khan AA. Ailawadhi S, et al. Among authors: wilding ge. Cancer. 2010 Jan 1;116(1):84-92. doi: 10.1002/cncr.24704. Cancer. 2010. PMID: 19862816 Free article. Clinical Trial.

2

Surgical management and outcome in primary adenocarcinoma of the small bowel.

Agrawal S, McCarron EC, Gibbs JF, Nava HR, Wilding GE, Rajput A. Agrawal S, et al. Among authors: wilding ge. Ann Surg Oncol. 2007 Aug;14(8):2263-9. doi: 10.1245/s10434-007-9428-2. Epub 2007 Jun 5. Ann Surg Oncol. 2007. PMID: 17549572

3

Safety and efficacy of first-line chemotherapy in unresected metastatic colorectal cancer.

Puthillath A, Dunn KB, Rajput A, Smith J, Yang G, Wilding GE, Tan W, Gupta B, Fakih MG. Puthillath A, et al. Among authors: wilding ge. Clin Colorectal Cancer. 2007 Nov;6(10):710-5. doi: 10.3816/CCC.2007.n.040. Clin Colorectal Cancer. 2007. PMID: 18039424

4

Qualitative radiology assessment of tumor response: does it measure up?

Gottlieb RH, Litwin A, Gupta B, Taylor J, Raczyk C, Mashtare T, Wilding G, Fakih M. Gottlieb RH, et al. Clin Imaging. 2008 Mar-Apr;32(2):136-40. doi: 10.1016/j.clinimag.2007.11.001. Clin Imaging. 2008. PMID: 18313578

5

Vascular endothelial growth factor polymorphisms in early-stage non-small-cell lung cancer.

Patel M, Ailawadhi S, Hernandez-Ilizaliturri F, Wilding GE. Patel M, et al. Among authors: wilding ge. J Clin Oncol. 2008 Jul 1;26(19):3289-90; author reply 3290. doi: 10.1200/JCO.2008.17.3880. J Clin Oncol. 2008. PMID: 18591568 No abstract available.

6

Multiple primary tumors in men with breast cancer diagnoses: a SEER database review.

Wernberg JA, Yap J, Murekeyisoni C, Mashtare T, Wilding GE, Kulkarni SA. Wernberg JA, et al. Among authors: wilding ge. J Surg Oncol. 2009 Jan 1;99(1):16-9. doi: 10.1002/jso.21153. J Surg Oncol. 2009. PMID: 18937232

7

A phase II study of first-line biweekly capecitabine and bevacizumab in elderly patients with metastatic colorectal cancer.

Puthillath A, Mashtare T Jr, Wilding G, Khushalani N, Steinbrenner L, Ross ME, Romano K, Wisniewski M, Fakih MG. Puthillath A, et al. Crit Rev Oncol Hematol. 2009 Sep;71(3):242-8. doi: 10.1016/j.critrevonc.2008.10.012. Epub 2008 Dec 10. Crit Rev Oncol Hematol. 2009. PMID: 19081732 Clinical Trial.

8

Adjuvant FOLFOX chemotherapy and splenomegaly in patients with stages II-III colorectal cancer.

Angitapalli R, Litwin AM, Kumar PR, Nasser E, Lombardo J, Mashtare T, Wilding GE, Fakih MG. Angitapalli R, et al. Among authors: wilding ge. Oncology. 2009;76(5):363-8. doi: 10.1159/000210025. Epub 2009 Mar 25. Oncology. 2009. PMID: 19321964

9

Treating octogenarian and nonagenarian acute myeloid leukemia patients--predictive prognostic models.

Harb AJ, Tan W, Wilding GE, Ford L, Sait SN, Block AW, Barcos M, Wallace PK, Wang ES, Wetzler M. Harb AJ, et al. Among authors: wilding ge. Cancer. 2009 Jun 1;115(11):2472-81. doi: 10.1002/cncr.24285. Cancer. 2009. PMID: 19322894 Free PMC article.

10

High-dose octreotide acetate for management of gastroenteropancreatic neuroendocrine tumors.

Chadha MK, Lombardo J, Mashtare T, Wilding GE, Litwin A, Raczyk C, Gibbs JF, Kuvshinoff B, Javle MM, Iyer RV. Chadha MK, et al. Among authors: wilding ge. Anticancer Res. 2009 Oct;29(10):4127-30. Anticancer Res. 2009. PMID: 19846960 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

277 results

Search Page

Filters